Literature DB >> 28179450

Prevalence, incidence and associated comorbidities of treated hypothyroidism: an update from a European population.

Carlo B Giorda1, Paolo Carnà2, Francesco Romeo1, Giuseppe Costa2,3, Barbara Tartaglino4, Roberto Gnavi2.   

Abstract

OBJECTIVE: Estimates of the prevalence of hypothyroidism in unselected populations date from the late 1990s. We present an update on the prevalence and incidence of overt hypothyroidism in Piedmont, northwest Italy and examine the association between hypothyroidism and multiple chronic comorbidities. DESIGN AND METHODS: Data were obtained from drug prescription and hospital discharge databases. Individuals who had received at least two levothyroxine prescriptions in 2012 were defined as having hypothyroidism; those who had undergone thyroidectomy or I131 irradiation in the previous 5 years were defined as having iatrogenic hypothyroidism and those who had either obtained exemption from treatment co-payment or had been discharged from hospital with a chronic comorbidity (diabetes and connective tissue diseases) were identified as having one of these conditions.
RESULTS: The overall crude prevalence was 31.1/1000 (2.3/1000 for iatrogenic hypothyroidism) and the overall crude incidence was 7/1000. The average daily dose of thyroxine (122 µg) roughly corresponded to 1.7 µg/kg. There was a strong association between hypothyroidism and diabetes (type 1, type 2 or gestational) and with autoimmune diseases, with the odds ratio ranging from 1.43 (1.02-1.99) for psoriatic arthritis to 4.99 (3.06-8.15) for lupus erythematosus.
CONCLUSIONS: As compared with previous estimates, the prevalence of hypothyroidism rose by about 35%, driven mainly by non-iatrogenic forms. The increase may be due to either population aging or improved diagnostic capability or both. The frequent co-occurrence of hypothyroidism with other multiple chronic conditions characterizes it more as a comorbidity rather than an isolated chronic disease.
© 2017 European Society of Endocrinology.

Entities:  

Mesh:

Year:  2017        PMID: 28179450     DOI: 10.1530/EJE-16-0559

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

1.  Hypothyroidism and Kidney Function: A Mendelian Randomization Study.

Authors:  Christina Ellervik; Samia Mora; Paul M Ridker; Daniel I Chasman
Journal:  Thyroid       Date:  2020-02-14       Impact factor: 6.568

2.  Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data.

Authors:  Jacopo Ciaffi; Maria Francesca Morabito; Piero Ruscitti; Salvatore D'Angelo; Luana Mancarella; Veronica Brusi; Giuseppina Abignano; Valentina Pucino; Roberto Giacomelli; Riccardo Meliconi; Francesco Ursini
Journal:  Rheumatol Int       Date:  2020-10-14       Impact factor: 2.631

Review 3.  Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis.

Authors:  Diogo Mendes; Carlos Alves; Nuno Silverio; Francisco Batel Marques
Journal:  Eur Thyroid J       Date:  2019-05-17

4.  Liothyronine and levothyroxine prescribing in England: A comprehensive survey and evaluation.

Authors:  Mike Stedman; Peter Taylor; Lakdasa Premawardhana; Onyebuchi Okosieme; Colin Dayan; Adrian H Heald
Journal:  Int J Clin Pract       Date:  2021-07-06       Impact factor: 3.149

5.  Evidence of earlier thyroid dysfunction in newly diagnosed oral lichen planus patients: a hint for endocrinologists.

Authors:  Paolo G Arduino; Dora Karimi; Federico Tirone; Veronica Sciannameo; Fulvio Ricceri; Marco Cabras; Alessio Gambino; Davide Conrotto; Stefano Salzano; Mario Carbone; Roberto Broccoletti
Journal:  Endocr Connect       Date:  2017-11       Impact factor: 3.335

6.  T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity.

Authors:  Wilmar M Wiersinga
Journal:  Endocrinol Metab (Seoul)       Date:  2021-09-30

Review 7.  The Burden of Hormonal Disorders: A Worldwide Overview With a Particular Look in Italy.

Authors:  Andrea Crafa; Aldo E Calogero; Rossella Cannarella; Laura M Mongioi'; Rosita A Condorelli; Emanuela A Greco; Antonio Aversa; Sandro La Vignera
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.